Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study

被引：0
|
作者：
Li-Han Hsu
Pei-Chi Hsu
Tien-Ling Liao
An-Chen Feng
Nei-Min Chu
Shu-Huei Kao
机构：
[1] Taipei Medical University,Ph.D. for Medical Biotechnology Program, College of Medical Science and Technology
[2] National Yang-Ming University Medical School,Department of Medicine
[3] Sun Yat-Sen Cancer Center,Division of Pulmonary and Critical Care Medicine
[4] College of Medical Science and Technology,School of Medical Laboratory Science and Biotechnology
[5] Taipei Medical University,Department of Research
[6] Sun Yat-Sen Cancer Center,Department of Medical Oncology
[7] Sun Yat-Sen Cancer Center,undefined
来源：
BMC Cancer | / 16卷
关键词：
Malignant pleural effusion; Osteopontin; Pleurodesis; Survival; Urokinase-type plasminogen activator; Vascular endothelial growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 6 条
  • [1] Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study
    Hsu, Li-Han
    Hsu, Pei-Chi
    Liao, Tien-Ling
    Feng, An-Chen
    Chu, Nei-Min
    Kao, Shu-Huei
    BMC CANCER, 2016, 16
  • [2] The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer
    Xue-wen Yang
    Feng Gao
    Ya-jun Chen
    Feng-meng Teng
    Cell Biochemistry and Biophysics, 2015, 72 : 649 - 652
  • [3] The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer
    Yang, Xue-wen
    Gao, Feng
    Chen, Ya-jun
    Teng, Feng-meng
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (03) : 649 - 652
  • [4] Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations
    Shimoda, Masafumi
    Tanaka, Yoshiaki
    Morimoto, Kozo
    Yoshimori, Kozo
    Ohta, Ken
    INTERNAL MEDICINE, 2023, 62 (24) : 3601 - 3607
  • [5] Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Yasue, Tomomi
    Nakao, Keiko
    Omachi, Naoki
    Shiroyama, Takayuki
    Tani, Eriko
    Hamaguchi, Masanari
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Atagi, Shinji
    Hirashima, Tomonori
    ANTICANCER RESEARCH, 2016, 36 (06) : 2939 - 2944
  • [6] Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients
    Konukoglu, Dildar
    Turhan, Mehtap Sultan
    Celik, Varol
    Turna, Hande
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2007, 125 (06) : 747 - 751
1